Boston Scientific’s WATCHMAN? Left Atrial Appendage (LAA) Closure Device has received the CE Mark for expanded indication. The new indication offers patients with atrial fibrillation (AF), and a contraindication to warfarin and the newer oral anticoagulants, a new treatment option for stroke reduction. The WATCHMAN is a permanent implant designed to capture harmful blood clots, which may cause the stroke. The device is introduced into the heart via a catheter through a vein in the groin, intended to close off the LAA. The device was approved for use in
LAA CLOSURE DEVICE
Source:Boston Scientific Corporation Release Date:2012-12-19 366
Medical Equipment
Add to Favorites
Add to Favorites
You May Like